Canlyniadau Chwilio - Walter E. Aulitzky

Mireinio'r Canlyniadau
  1. 1
    RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38

    RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38 gan Andrea Weilbacher, Matthias Gutekunst, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571)

    Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571) gan Lara Wohlbold, Heiko van der Kuip, Cornelius Miething, Hans‐Peter Vornlocher, Cornelius Knabbe, Justus Duyster, Walter E. Aulitzky

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells

    Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells gan Markus Kleih, Kathrin Böpple, Meng Dong, Andrea Gaißler, Simon Heine, Monilola A. Olayioye, Walter E. Aulitzky, Frank Eßmann

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION

    ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION gan D Niederwieser, Magdolna Herold, W. Woloszczuk, Walter E. Aulitzky, Bernhard Meister, Herbert Tilg, Guenther Gastl, RA Bowden, C. Huber

    Cyhoeddwyd 1990
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts

    Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts gan Silke Haubeiß, Jens O. Schmid, Thomas E. Mürdter, Maike Sonnenberg, Godehard Friedel, Heiko van der Kuip, Walter E. Aulitzky

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin

    p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin gan Matthias Gutekunst, Moshe Oren, Andrea Weilbacher, Michael A. Dengler, Christiane Markwardt, Jürgen Thomale, Walter E. Aulitzky, Heiko van der Kuip

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair

    BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair gan Kimberly Cramer, Margaret Nieborowska-Skorska, Mateusz Koptyra, Artur Słupianek, Emir Tyrone P. Penserga, Connie J. Eaves, Walter E. Aulitzky, Tomasz Skórski

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4

    Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4 gan Matthias Gutekunst, Thomas Mueller, Andrea Weilbacher, Michael A. Dengler, Jens Bedke, Stephan Kruck, Moshe Oren, Walter E. Aulitzky, Heiko van der Kuip

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

    Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast gan Maike Sonnenberg, Heiko van der Kuip, Silke Haubeiß, Péter Fritz, Werner Schroth, Godehard Friedel, Wolfgang Simon, Thomas E. Mürdter, Walter E. Aulitzky

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

    Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment gan Heiko van der Kuip, Thomas E. Mürdter, Maike Sonnenberg, Monika McClellan, Susanne Gutzeit, A Gerteis, Wolfgang Simon, Péter Fritz, Walter E. Aulitzky

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles’ heel in mantle cell lymphoma

    Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles’ heel in mantle cell lymphoma gan Michael A. Dengler, Andrea Weilbacher, Matthias Gutekunst, Annette M. Staiger, Matthias Vöhringer, Heike Horn, German Ott, Walter E. Aulitzky, Heiko van der Kuip

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest

    Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest gan Lea Schaaf, Matthias Schwab, Christoph Ulmer, Simon Heine, Thomas E. Mürdter, Jens O. Schmid, Georg Sauer, Walter E. Aulitzky, Heiko van der Kuip

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network

    A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central... gan K. Mross, Christian Dittrich, Walter E. Aulitzky, Dirk Strumberg, J. Schütte, Roland M. Schmid, S. Hollerbach, Michael Merger, Gerd Munzert, Frank Fleischer, M. E. Scheulen

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features

    Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features gan Sharathchandra Arandkar, Noa Furth, Yair Elisha, Nishanth Belugali Nataraj, Heiko van der Kuip, Yosef Yarden, Walter E. Aulitzky, Igor Ulitsky, Benjamin Geiger, Moshe Oren

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Treatment-Related Mortality in Patients With Advanced-Stage Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group

    Treatment-Related Mortality in Patients With Advanced-Stage Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group gan Diana Wongso, Michael Fuchs, Annette Plütschow, Beate Klimm, Stephanie Sasse, Bernd Hertenstein, Georg Maschmeyer, Tom Vieler, Ulrich Dührsen, Walter Lindemann, Walter E. Aulitzky, Volker Diehl, Peter Borchmann, Andreas Engert

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia

    Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia gan Annika Nelde, Yacine Maringer, Tatjana Bilich, Helmut R. Salih, Malte Roerden, Jonas S. Heitmann, Ana Marcu, Jens Bauer, Marian C. Neidert, Claudio Denzlinger, Gerald Illerhaus, Walter E. Aulitzky, Hans‐Georg Rammensee, Juliane S. Walz

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial

    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial gan Thomas Elter, Peter Borchmann, H. Schulz, Marcel Reiser, Sven Trelle, Roland Schnell, Markus Jensen, Peter Staib, Timo Schinköthe, H. Stützer, Jürgen Rech, Martin Gramatzki, Walter E. Aulitzky, Ibrahim Hasan, Andreas Josting, Michael Hallek, Andreas Engert

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy

    Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy gan Maria Hägg Olofsson, Takayuki Ueno, Yang Pan, Ren Xu, Feng Cai, Heiko van der Kuip, Thomas Muerdter, Maike Sonnenberg, Walter E. Aulitzky, Stephan Schwarz, Elina Andersson, Maria C. Shoshan, Aleksandra Mandic Havelka, Masakazu Toi, Stig Linder

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System

    Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting Sys... gan Christoph Röllig, Martin Bornhäuser, Christian Thiede, Franziska Taube, Michael Krämer, Brigitte Mohr, Walter E. Aulitzky, H. Bodenstein, Hans‐Joachim Tischler, Reingard Stuhlmann, Ulrich S. Schuler, Friedrich Stölzel, Malte von Bonin, Hannes Wandt, Kerstin Schäfer‐Eckart, Markus Schaich, Gerhard Ehninger

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

    A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial gan Christoph Röllig, Christian Thiede, Martin Gramatzki, Walter E. Aulitzky, H. Bodenstein, Martin Bornhäuser, Uwe Platzbecker, Reingard Stuhlmann, Ulrich S. Schuler, Silke Soucek, Michael Krämer, Brigitte Mohr, Uta Oelschlaegel, Friedrich Stölzel, Malte von Bonin, Martin Wermke, Hannes Wandt, Gerhard Ehninger, Markus Schaich

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: